The more optimal glycaemic control, as a result of utilizing CGM, seems to positively influence lipid profiles, possibly through preventing the extreme fluctuations of glucose, promoting a more stable glycemic condition by reducing hypoglycemic episodes and enabling timely management of hyperglycemia with additional insulin boluses. The gene discussed is INS; the disease is Hyperglycemia.